First report of SME-carbapenemase–producing Serratia marcescens in France
- 19 March 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (5) , 1457-1461
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- First nosocomial outbreak of SME-4-producing Serratia marcescens in South AmericaRevista Argentina de Microbiologia, 2023
- SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogenyJournal of Antimicrobial Chemotherapy, 2019
- Ceftazidime/avibactam susceptibility by three different susceptibility testing methods in carbapenemase-producing Gram-negative bacteria from AustraliaInternational Journal of Antimicrobial Agents, 2018
- Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapyJournal of Antimicrobial Chemotherapy, 2018
- Serratia marcescens harboring SME-4 in Brazil: A silent threatDiagnostic Microbiology and Infectious Disease, 2017
- Serratia marcescensproducing SME carbapenemases: an emerging resistance problem in the UK?Journal of Antimicrobial Chemotherapy, 2017
- Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1Journal of Antimicrobial Chemotherapy, 2014
- Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in DetroitDiagnostic Microbiology and Infectious Disease, 2011
- Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)Microbial Drug Resistance, 2006
- Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeDiagnostic Microbiology and Infectious Disease, 2001